We recently observed that PMN myeloid-derived suppressor cells (PMN-MDSCs) from several solid cancer patients (Fig. 5E), melanoma and colorectal cancer patients have elevated CD89 expression as well (unpublished data). This evidence concerns the gene FCAR and colorectal cancer.